Basic Information
Basic information for LINC01814-203-14aa-2
Peptide Name LINC01814-203-14aa-2
Genome Position chr2:8566062-8566103[-]
Species Human
Peptide Sequence MWRNRNTFTLLVGL
Peptide Length 14
Unique No (AL355916.1-202-14aa,AL590867.1-201-14aa,LINC00355-201-14aa,LINC00504-201-14aa-1,AC010733.2-201-14aa-1,AC007998.4-201-14aa,AC022929.2-201-14aa-2,AC245060.6-201-14aa-2,AC068587.4-203-14aa-2,AC007262.2-201-14aa,AC092661.1-201-14aa-1,AP001977.1-202-14aa,AC007262.2-202-14aa,AL590807.1-206-14aa-3,AC072026.2-204-14aa-2,PRKG1-AS1-206-14aa-3,AF117829.1-213-14aa-1,LINC02254-208-14aa-2,LINC00639-210-14aa-1,HIF1A-AS3-202-14aa-2,AC072026.2-202-14aa-1,AC072026.2-203-14aa-1,AC090825.1-217-14aa,LINC00639-213-14aa)
Grand Average of Hydropathicity 0.1143
Relative Molecular Mass 1955.31
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000236008;LINC01814
Transcript ID/Name ENST00000454224;LINC01814-203
Transcript Length 8839
Coding Ability 0.4814
DNA Sequence Corresponding to Peptide ATGTGGAGAAATAGGAACACTTTTACACTGTTGGTGGGACTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :